Viveon Health Acquisition Corp.

  • Market Cap: Micro Cap
  • Industry: Financial Conglomerates
  • ISIN: US92853V1061
USD
10.81
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

0

Shareholding (Dec 2023)

FII

59.41%

Held by 11 FIIs

DII

36.31%

Held by 2 DIIs

Promoter

3.76%

How big is Viveon Health Acquisition Corp.?

22-Jun-2025

As of Feb 22, Viveon Health Acquisition Corp. has a market capitalization of 66.49 million and reported net sales of 0.00 million with a net profit of 1.18 million for the latest four quarters ending in March 2023.

Market Cap: As of Feb 22, Viveon Health Acquisition Corp. has a market capitalization of 66.49 million, classified as a Micro Cap.<BR><BR>Recent Quarterly Performance: For the latest four quarters ending in March 2023, Viveon Health Acquisition Corp. reported net sales of 0.00 million and a net profit of 1.18 million.<BR><BR>Balance Sheet Snapshot: As of December 2022, the company reported shareholder's funds of 3.22 million and total assets of 53.92 million.

Read More

What does Viveon Health Acquisition Corp. do?

22-Jun-2025

Viveon Health Acquisition Corp. is a micro-cap company in the financial conglomerates industry with a market cap of $66.49 million and reported no net profit as of March 2023. Key metrics include a P/E ratio of NA, a dividend yield of 0.00%, and a return on equity of -125.37%.

Overview:<BR>Viveon Health Acquisition Corp. operates in the financial conglomerates industry and is classified as a micro-cap company.<BR><BR>Financial Snapshot:<BR>- Most recent Net Profit: 0 Million (Quarterly Results - Mar 2023)<BR>- Market cap: USD 66.49 Million<BR>- Category: Micro Cap<BR><BR>Key Metrics:<BR>- P/E: NA (Loss Making)<BR>- Industry P/E: NA<BR>- Dividend Yield: 0.00%<BR>- Debt Equity: -999,999.00<BR>- Return on Equity: -125.37%<BR>- Price to Book: 18.57<BR><BR>Contact Details:<BR>Registrar Address: Not available.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Financial Conglomerates

stock-summary
Market cap

USD 66 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-999,999.00

stock-summary
Return on Equity

-125.37%

stock-summary
Price to Book

18.57

Revenue and Profits:
Net Sales:
(Quarterly Results - Mar 2023)
Net Profit:
0 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-4.34%
0%
-4.34%
6 Months
-2.88%
0%
-2.88%
1 Year
1.03%
0%
1.03%
2 Years
7.35%
0%
7.35%
3 Years
6.82%
0%
6.82%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Viveon Health Acquisition Corp. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
-155.68%
EBIT to Interest (avg)
-2.75
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
18.57
EV to EBIT
-30.73
EV to EBITDA
-30.73
EV to Capital Employed
8.85
EV to Sales
NA
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-28.79%
ROE (Latest)
-125.37%
Technicals key factors
Indicator
Weekly
Monthly
Icon
Technical indicator has not been calculated since the stock has been active for a short period
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2023stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 2 Schemes (0.52%)

Foreign Institutions

Held by 11 Foreign Institutions (59.41%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'23 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2023 is 0.00% vs 0.00% in Dec 2022",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2023 is -89.29% vs 216.67% in Dec 2022",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'23",
        "Dec'22",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.60",
          "val2": "-0.10",
          "chgp": "-500.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "2.50",
          "chgp": "-100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.50",
          "val2": "4.90",
          "chgp": "-89.80%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "0.30",
          "val2": "2.80",
          "chgp": "-89.29%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'22",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2022 is 0.00% vs 0.00% in Dec 2021",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2022 is -124.00% vs 213.64% in Dec 2021",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'22",
        "Dec'21",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-2.50",
          "val2": "-4.10",
          "chgp": "39.02%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "3.60",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "4.90",
          "val2": "6.60",
          "chgp": "-25.76%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-0.60",
          "val2": "2.50",
          "chgp": "-124.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Mar'23 - QoQstock-summary
Mar'23
Dec'22
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-0.60
-0.10
-500.00%
Interest
0.00
2.50
-100.00%
Exceptional Items
0.50
4.90
-89.80%
Consolidate Net Profit
0.30
2.80
-89.29%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
USD in Million.
Net Sales

QoQ Growth in quarter ended Mar 2023 is 0.00% vs 0.00% in Dec 2022

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Mar 2023 is -89.29% vs 216.67% in Dec 2022

Annual Results Snapshot (Consolidated) - Dec'22stock-summary
Dec'22
Dec'21
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-2.50
-4.10
39.02%
Interest
3.60
0.00
Exceptional Items
4.90
6.60
-25.76%
Consolidate Net Profit
-0.60
2.50
-124.00%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
USD in Million.
Net Sales

YoY Growth in year ended Dec 2022 is 0.00% vs 0.00% in Dec 2021

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2022 is -124.00% vs 213.64% in Dec 2021

stock-summaryCompany CV
About Viveon Health Acquisition Corp. stock-summary
stock-summary
Viveon Health Acquisition Corp.
Financial Conglomerates
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available